Clinical Trial Update: Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer

View source ↗

Summary

This clinical trials registry entry reports the development and validation of a prediction model for acute kidney injury after cisplatin-based HIPEC in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Ovarian Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Ovarian Cancer, AKI - Acute Kidney Injury | Status: COMPLETED